학술논문
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Document Type
Article
Author
Fizazi, Karim; Scher, Howard I; Molina, Arturo; Logothetis, Christopher J; Chi, Kim N; Jones, Robert J; Staffurth, John N; North, Scott; Vogelzang, Nicholas J; Saad, Fred; Mainwaring, Paul; Harland, Stephen; Goodman, Oscar B, Jr; Sternberg, Cora N; Li, Jin Hui; Kheoh, Thian; Haqq, Christopher M; de Bono, Johann S
Source
In Lancet Oncology October 2012 13(10):983-992
Subject
Language
ISSN
1470-2045